OBI Pharma
LightNews LightNews
banner
obipharma.bsky.social
OBI Pharma
@obipharma.bsky.social
9 followers 5 following 40 posts
Posts Replies Media Videos
obipharma.bsky.social
Happy Holidays 🎄✨ and best wishes for a wonderful 2026 🌍🎯
Thank you for your continued trust and support 🤝

#OBIPharma #SeasonGreetings #MerryXMas #HappyHolidays #BestWishes #Grateful #Partnership #LookingAhead
December 23, 2025 at 7:18 AM
obipharma.bsky.social
🤝浩鼎與美國 TegMine Therapeutics 簽訂受其委託開發之醣蛋白 ADC 全球專屬授權合約
🌏此次國際授權合作，展現以浩鼎 Obrion™ ADC 技術所開發產品的應用前景🚀
#OBIPharma #Obrion #GlycOBI #Glycoprotein #ADC #ExclusiveLicense #GlobalPartnership

www.obipharma.com/zh-hant/news...
www.obipharma.com
December 19, 2025 at 7:11 AM
obipharma.bsky.social
OBI held the 2025 Investors’ Meeting, outlining progress in ADC R&D and clinical development, business strategy, and operating efficiency, while advancing next-generation ADC technologies.
#OBIPharma #ADC #Oncology #PrecisionMedicine #InvestorsMeeting

www.obipharma.com/news/obi-inv...
www.obipharma.com
December 18, 2025 at 9:10 AM
obipharma.bsky.social
🎉OBI presented new preclinical results for our bispecific ADC OBI-201 at
@sabcs.bsky.social #SABCS2025, led by our CSO Ya-Chi Chen and the R&D team.
#OBIPharma #OBI201 #ADC #BispecificADC #SABCS2025 #BreastCancerResearch #TROP2

www.obipharma.com/news/obi-201...
OBI Pharma Presents Preclinical Results for Bispecific ADC OBI-201 at SABCS 2025 - OBI Pharma 台灣浩鼎
Highlighting OBI-201’s Antitumor Activity and Payload Delivery Performance Across Multiple Tumor Animal Models OBI Pharma (4174.TWO) presented the preclinical results of OBI-201, at the 2025 San Anton...
www.obipharma.com
December 9, 2025 at 7:30 AM
obipharma.bsky.social
🎉 OBI-902 receives a Second FDA Orphan Drug Designation, this time for gastric cancer including gastroesophageal junction adenocarcinoma.
We remain committed to advancing OBI-902 in areas of high unmet medical need. 🔬
#ADC #OBI902 #TROP2 #GlycOBI #ODD #GC #GEJC

www.obipharma.com/news/obi-902...
www.obipharma.com
December 5, 2025 at 7:16 AM
obipharma.bsky.social
🎙️OBI Pharma at the 2025 Fubon Biotech Corporate Day
📍 Taipei | 2025/12/05 | 13:20–14:10 session
📣 OBI has been invited to join the 2025 Fubon Biotech Corporate Day, organized by Fubon Securities Co. Ltd. at the PCBC Conference Center.
#FubonSecurities #FubonBiotechCorporateDay
December 2, 2025 at 6:37 AM
obipharma.bsky.social
OBI’s TROP2 ADC OBI-902 has been granted Orphan Drug Designation by the U.S. FDA for the treatment of cholangiocarcinoma, a rare and aggressive cancer with limited treatment options.
#OBIPharma #OBI902 #ADC #OrphanDrugDesignation #Cholangiocarcinoma

www.accessnewswire.com/newsroom/en/...
www.accessnewswire.com
November 18, 2025 at 12:13 AM
obipharma.bsky.social
OBI CSO Dr. Ya-Chi Chen was invited by
Yang Ming Chiao Tung University to deliver a Special Lecture on Biomedicine.
We appreciate NYCU’s Institute of Biopharmaceutical Sciences for the warm invitation
#ADC #OBIPharma #Biotech #DrugDevelopment #YangMingChiaoTungUniversity #cls_nycu
November 14, 2025 at 1:18 AM
obipharma.bsky.social
🌍 Guardians of our planet
On October, the OBI Pharma Welfare Committee hosted a corporate movie night featuring Guardians of Our Planet, an ecological documentary. This inspiring movie reminded us that sustainability begins with everyday choices.💚
#守護我們的星球 #GuardiansOfOurPlanet #Sustainability #ESG
November 3, 2025 at 6:34 AM
obipharma.bsky.social
🎀浩鼎志工熱情響應粉紅十月！
🎀OBI Volunteers Shine in Pink October!

浩鼎志工參與 TBCA「點亮雙色粉紅絲帶」活動💗
已連續第十一年投入志工行列，持續以行動支持乳癌防治與病友關懷 💪
#OBIPharma #PinkOctober #BreastCancerAwareness #Volunteer #TBCA #TeamOBI

www.obipharma.com/zh-hant/news...
October 21, 2025 at 8:04 AM
obipharma.bsky.social
浩鼎董事長梁賡義院士榮獲2024–2025年總統科學獎生命科學組獎項
Dr. Kung-Yee Liang, Chairman of OBI Pharma, has received the 2024–2025 Presidential Science Prize in the category of Life Sciences.
#總統科學獎 #PresidentialSciencePrize #LifeSciences

www.president.gov.tw/News/39520
www.president.gov.tw
October 8, 2025 at 9:24 AM
obipharma.bsky.social
Convergence 2025: Adapting to change and uncertainty in the regulatory landscape
www.raps.org/news-and-art...
@MichelleMeng, VP and Head of Global Regulatory Sciences at OBI Pharma, was featured in RAPS Regulatory News.
#OBIPharma #RAPSConvergence #RegulatoryAffairs #ConvergenceCommitteemembers
www.raps.org
October 8, 2025 at 7:21 AM
obipharma.bsky.social
🌕✨ Wishing everyone a joyful Mid-Autumn Festival!
🤝 Celebrate meaningful collaborations
🏠 Enjoy precious time with loved ones
Happy Mid-Autumn Festival! 🌸🥮
#OBIPharma #MidAutumnFestival #MoonFestival #Partnership #Collaboration
October 2, 2025 at 6:52 AM
obipharma.bsky.social
👏 Honored for OBI to take part in Biologics World Korea 2025
ADC Bioconjugate East Asia #ADCBio2025 (lnkd.in/e3cExQ-6)
#IMAPAC #BMK2025 #AntibodyDrugConjugates #PrecisionMedicine #LifeSciences

www.obipharma.com/news/biologi...
lnkd.in
September 26, 2025 at 7:50 AM
obipharma.bsky.social
✨Great discussions at the Integrated Strategies for Early-Stage ADC Development seminar
Dr. Wei-Han Lee — Leveraging Platform Knowledge for Successful ADC Process Development
Dr. Nan-Hsuan Wang— Obrion Engine™: Driving Multi-Platform Innovations for the Next Generation of ADC
#ADC #ADCPlatform
September 25, 2025 at 1:46 AM
obipharma.bsky.social
Our CEO, Dr. Heidi Wang, joined the #DoseOfReality podcast with Charles Spence, founder of Discera Search.
Listen here:
🎧 Spotify: lnkd.in/gaGmpyci
🎧 Apple Podcast: lnkd.in/gYHvyhv6
🌐 Website: lnkd.in/g-SR7mMf
#PodcastInterview #DisceraSearch #OBIPharma

www.discera-search.com/podcast/losi...
Discera Search
In this episode, Charles is joined by Heidi Wang, CEO of OBI Pharma and Chair of OBIGEN, who shares her powerful story, from losing her father to cancer while raising two children, to leading oncology drug approvals at BMS, and now, building out an ADC pipeline in biotech.
www.discera-search.com
September 22, 2025 at 8:47 AM
obipharma.bsky.social
恭賀我們的合作夥伴 深圳 #艾欣达伟医药科技有限公司：
授權 AST-3424（亦稱 OBI-3424）在中國大陸、香港及澳門的權益(研發、註冊、生產及商業化)予浙江 #海正藥業股份有限公司 (Zhejiang Hisun Pharmaceutical)
ascentawits.com/CompanyNews/...

#OBIPharma #Ascentawits #HisunPharma
#AST3424 #OBI3424
ascentawits.com
September 22, 2025 at 2:04 AM
obipharma.bsky.social
OBI Pharma is excited to announce a technology collaboration with AP Biosciences, Inc. to develop a next-generation bispecific Antibody-Drug Conjugate (ADC). 🤝
🔗 Learn more: www.obipharma.com/news/obi-pha...

#OBIPharma #APBiosciences #ADC #GlycOBI #Innovation #Partnership
www.obipharma.com
September 3, 2025 at 7:38 AM
obipharma.bsky.social
🚀 OBI Pharma has enrolled the first patient in our Phase 1/2 clinical trial of OBI-902, our first TROP2-targeted ADC built with our proprietary GlycOBI® technology.
🔗 Learn more: www.globenewswire.com/news-release...
#OBIPharma #ADC #ClinicalTrials
#GlycOBI #OBI902 #Phase1 #firstpatientin
www.globenewswire.com
September 2, 2025 at 9:19 AM
obipharma.bsky.social
At the 2025 Taiwan Society for Immunotherapy of Cancer (TSITC) Summer Meeting,
OBI Pharma CEO Dr. Heidi Wang presented on:
📌Insights from US FDA rejection letters (CRLs)
📌Principles and key considerations in drug development
#OBIPharma #ADCs #TSITC2025 #DrugDevelopment #PrecisionMedicine #OBI902
August 26, 2025 at 12:41 AM
obipharma.bsky.social
2025 OBI 桌球趣味競賽🏓
從球拍到湯匙，創意無限的團隊時光
📹 一起感受我們的創意精神與滿滿能量👑
這場趣味競賽中發揮創意、團隊合作，贏得掌聲與笑聲。
#OBIPharma #TeamOBI #LifeAtOBI
#Innovation #BeyondTheLab
#InternalEngagement #WorkplaceCulture
August 5, 2025 at 8:25 AM
obipharma.bsky.social
On 7/28, OBI welcomed the 2025 BIO Asia–Taiwan tour at Taipei Bioinnovation Park. Guests toured our Enzyme, CMC, Biology, and QC labs, exploring our ADC research. Thanks to our team for showcasing OBI’s next-gen therapeutics! #OBIPharma #BIOAsiaTaiwan2025 #TBIP #ADC #LabTour #GlycOBI
July 29, 2025 at 9:11 AM
obipharma.bsky.social
OBI Pharma at #BIOAsia2025
7/24, our CEO Dr. Heidi Wang moderated two high-impact sessions (A-6 & A-7) at the 2025 Innovation Forum
#GlycOBI #ADC #OBIPharma #DualPayload #InnovationForum #AntibodyConjugates #InnovationLeadership #Biotech #BIOAsia2025
July 25, 2025 at 8:09 AM
obipharma.bsky.social
【BIO Asia–Taiwan 2025｜the Investment Summit】
Today (7/23), our CEO Dr. Heidi Wang joined the Investment Summit on the 7th floor of the TaiNEX2, delivering OBI Pharma’s roadshow presentation.
#BIOAsiaTaiwan2025
#OBIPharma #ADC #GlycOBI #PrecisionMedicine #InvestmentSummit
July 23, 2025 at 10:40 AM
obipharma.bsky.social
【BIO Asia–Taiwan 2025｜OBI & OBIGEN 】
📍7/23 13:50–15:10｜OBI Roadshow
📍7/23 17:20–17:55｜OBIGEN Roadshow
📍7/24 14:40–15:05｜Innovation Forum Talk
📍7/24 16:30–17:10｜Panel Discussion

#OBIPharma #BIOAsiaTaiwan2025 #ADC #OBIGEN #PrecisionMedicine

www.obipharma.com/news/obi-pha...
www.obipharma.com
July 22, 2025 at 9:27 AM